MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
Clinical trials for MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS explained in plain language.
Never miss a new study
Get alerted when new MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS trials appear
Sign up with your email to follow new studies for MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for ulcerative colitis: drug trial targets chinese patients
Disease control OngoingThis study tests whether vedolizumab, given as an IV infusion, can help Chinese adults with moderate to severe ulcerative colitis. About 392 participants will receive either the drug or a placebo to see if it reduces symptoms like diarrhea and bleeding, and helps achieve remissio…
Matched conditions: MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated May 26, 2026 11:49 UTC
-
New hope for ulcerative colitis sufferers: phase 3 drug trial underway
Disease control OngoingThis study tests a new medicine called RO7790121 for people with moderate to severe ulcerative colitis, a condition that causes inflammation and sores in the colon. About 400 adults who haven't responded well to other treatments will receive either the drug or a placebo. The goal…
Matched conditions: MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 26, 2026 11:48 UTC